Riskpilot← Back to searchSign inGet full accessITdrenaline AB
ABActiveOrg 5591268213Maj På Malös Gata 29Computer programming activities · NACE 6210Est. 20171 employees
Revenue 2025
SEK 1,4M
+40% vs 2024
EBITDA margin
31.9%
+92% vs 2024
Equity ratio
68.8%
Financial strength
Net profit 2025
SEK 378K
+67% vs 2024
| Revenue | SEK 1,4M | +40% |
| EBITDA | SEK 450K | +92% |
| Net profit | SEK 378K | +67% |
| Total assets | SEK 1,5M | +37% |
| Equity | SEK 1M | +58% |
| Employees | 1 | — |
Legal name
ITdrenaline AB
Org number
5591268213
Legal form
Aktiebolag
NACE code
6210 · Computer programming activities
Founded
27 september 2017
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget ska bedriva konsultverksamhet inom IT, försäljning samt utveckling av mjukvara, äga och förvalta såväl fast som lös egendom. Bolaget ska även bedriva handel med värdepapper, fastigheter och därmed förenlig verksamhet.
Address
Maj På Malös Gata 29
Email
zang.phu@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 1 291 | 1 383 | 1 415 | 1 009 | 1 411 |
| Staff expenses | — | −774 | −853 | −729 | −892 |
| EBITDA | 499 | 558 | 502 | 234 | 450 |
| Depreciation & amort. | −0 | — | −4 | −5 | −5 |
| EBIT | 499 | 558 | 498 | 228 | 445 |
| Net financials | −1 | 1 | 13 | 13 | 1 |
| Profit before tax | 498 | 559 | 387 | 291 | 481 |
| Tax | −103 | −116 | −81 | −64 | −103 |
| Net profit | 395 | 443 | 306 | 227 | 378 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 1 407 | 1 381 | 1 378 | 1 096 | 1 498 |
| Equity | 977 | 920 | 826 | 653 | 1 031 |
| Long-term debt | 0 | — | — | — | — |
| Short-term debt | 131 | 161 | 127 | 68 | 127 |
| Total debt | 131 | 161 | 127 | 68 | 127 |
EBITDA margin
31.9%
This company
15.8%
Market median
+102% vs market
20212025
Equity ratio
68.8%
This company
38.2%
Market median
+80% vs market
20212025
Return on equity
36.7%
This company
18.4%
Market median
+99% vs market
20212025
Net profit margin
26.8%
This company
8.1%
Market median
+231% vs market
20212025
Asset turnover
0.94×
This company
1.12×
Market median
+16% vs market
20212025
Debt / equity
0.45×
This company
0.62×
Market median
+27% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of ITdrenaline AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Kong Sang Fu | Board of Directors | 0 companies |
| Anna Maria Johansson | Deputy Board Member | 0 companies |